Moderna, BioNTech Leads Covid Sell-Off After Pfizer Slashes Outlook – Investor's Business Daily
Business News
- Moderna, BioNTech Leads Covid Sell-Off After Pfizer Slashes Outlook Investor’s Business Daily
- Pfizer cuts guidance on slumping COVID vaccine, treatment sales Yahoo Finance
- Pfizer Stock: Brutal End To COVID Gravy Train (NYSE:PFE) Seeking Alpha
- Pfizer’s earnings cut was ‘sort of telegraphed’, says E Squared’s Les Funtleyder CNBC Television
- BioNTech writes down €900mn on Covid-19 vaccines Financial Times
- View Full Coverage on Google News
Source: Business News